Alcoholism is the number one cause of liver disease, as breaking down alcohol can cause the liver to produce harmful substances that damage the organ's cells and cause scar tissue to form. The most ...

Inventiva (IVA) announced the publication in Biomedicine & Pharmacotherapy, a peer-reviewed, scientific journal, of the results from a ...

Hollywood is mourning the loss of another young life, and with the news of Michelle Trachtenberg’s death, there have been a ...

I n today’s fast-paced world, we’re constantly bombarded with toxins, processed foods and stress. It’s no wonder many of us ...

Investing.com -- Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ: NASDAQ: MDGL) rose 17% following the announcement of their fourth-quarter and full-year 2024 financial results, which included a ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported two-year results from the open-label compensated MASH cirrhosis (F4c) ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra, the first approved drug for MASH, showed strong sales growth, with Q4 net sales ...

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated ...

Fatty liver is a health crisis that occurs when more than 5% of fat builds up in the liver due to various behavioural and ...

Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...